Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case report

We report on an elderly patient with MPAL treated with venetoclax combined with azacitidine. This regimen successfully induced complete remission with no adverse side effects, and despite testing positive for COVID-19 multiple times during induction therapy, accompanied by mild dry cough but no radiographic evidence of pneumonia, the patient remained clinically stable.